Analystreport

CollPlant Biotechnologies (CLGN) had its "sell (e+)" rating reaffirmed by Weiss Ratings.

CollPlant Biotechnologies Ltd. - Ordinary Shares  (CLGN) 
US:NASDAQ Investor Relations: collplant.com/investor-relation